SLC5A5, solute carrier family 5 member 5, 6528

N. diseases: 195; N. variants: 8
Disease: Refractory Thyroid Gland Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4684942
Disease: Refractory Thyroid Gland Carcinoma
Refractory Thyroid Gland Carcinoma 		0.020 Biomarker disease BEFREE SIGNIFICANCE: These findings show that ARF4 and VCP are involved in NIS trafficking to the plasma membrane and highlight the possible therapeutic role of VCP inhibitors in enhancing radioiodine effectiveness in radioiodine-refractory thyroid cancer. 31672844 2020
CUI: C4684942
Disease: Refractory Thyroid Gland Carcinoma
Refractory Thyroid Gland Carcinoma 		0.020 Biomarker disease BEFREE Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system. 29467951 2018